APO Research
Talk to an analyst

APO RESEARCH · REPORT

Canine Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Canine Vaccine Industry Growth and Trends Forecast to 2032

26 December 2025116 pages

Choose your research edition.

Industry ResearchCanine Vaccine Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Canine Vaccine Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Canine Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Canine Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Canine Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Canine Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Canine Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Canine Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Canine Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Canine Vaccine include Biogenesis Bago, Boehringer Ingelheim, Durvet, NeoTech, Virbac, Pfizer, Jilin Five-Star Animal Health, JINHE and Wuhan Keqian Biology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Canine Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Canine Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Canine Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Canine Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Canine Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Canine Vaccine Market by Company

Biogenesis Bago

Boehringer Ingelheim

Durvet

NeoTech

Virbac

Pfizer

Jilin Five-Star Animal Health

JINHE

Wuhan Keqian Biology

SINOVAC

Elanco

Merck Animal Health

RuiPu Bio-Technology

Zoetis

CAHIC

Canine Vaccine Segment by Type

Core Vaccines

Non-Core Vaccines

Canine Vaccine Segment by Application

Puppies

Adult Dogs

Canine Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Canine Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Canine Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Canine Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Core Vaccines Table 2. Major Company of Non-Core Vaccines Table 3. Global Canine Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Canine Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Canine Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Canine Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Canine Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Canine Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Canine Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Canine Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Canine Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Canine Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Canine Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Canine Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Canine Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Canine Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Canine Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Canine Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Canine Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Canine Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Canine Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Canine Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Canine Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Canine Vaccine Industry Trends Table 25. Canine Vaccine Industry Drivers Table 26. Canine Vaccine Industry Opportunities and Challenges Table 27. Canine Vaccine Industry Restraints Table 28. Global Canine Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Canine Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Canine Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Canine Vaccine Sales Share by Company (2021-2026) Table 32. Global Canine Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Canine Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Canine Vaccine Major Company Production Sites and Headquarters Table 35. Global Canine Vaccine Company, Product Type & Application Table 36. Global Canine Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Canine Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Canine Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Canine Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Canine Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Canine Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Canine Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Canine Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Canine Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Canine Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Canine Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Canine Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Canine Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Canine Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Canine Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Canine Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Canine Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Canine Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Canine Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Canine Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Canine Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Canine Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Canine Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Canine Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Canine Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Canine Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Canine Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Canine Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Canine Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Canine Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Canine Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Canine Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Biogenesis Bago Company Information Table 72. Biogenesis Bago Business Overview Table 73. Biogenesis Bago Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Biogenesis Bago Canine Vaccine Product Portfolio Table 75. Biogenesis Bago Recent Development Table 76. Boehringer Ingelheim Company Information Table 77. Boehringer Ingelheim Business Overview Table 78. Boehringer Ingelheim Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Boehringer Ingelheim Canine Vaccine Product Portfolio Table 80. Boehringer Ingelheim Recent Development Table 81. Durvet Company Information Table 82. Durvet Business Overview Table 83. Durvet Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Durvet Canine Vaccine Product Portfolio Table 85. Durvet Recent Development Table 86. NeoTech Company Information Table 87. NeoTech Business Overview Table 88. NeoTech Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. NeoTech Canine Vaccine Product Portfolio Table 90. NeoTech Recent Development Table 91. Virbac Company Information Table 92. Virbac Business Overview Table 93. Virbac Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Virbac Canine Vaccine Product Portfolio Table 95. Virbac Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Pfizer Canine Vaccine Product Portfolio Table 100. Pfizer Recent Development Table 101. Jilin Five-Star Animal Health Company Information Table 102. Jilin Five-Star Animal Health Business Overview Table 103. Jilin Five-Star Animal Health Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Jilin Five-Star Animal Health Canine Vaccine Product Portfolio Table 105. Jilin Five-Star Animal Health Recent Development Table 106. JINHE Company Information Table 107. JINHE Business Overview Table 108. JINHE Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. JINHE Canine Vaccine Product Portfolio Table 110. JINHE Recent Development Table 111. Wuhan Keqian Biology Company Information Table 112. Wuhan Keqian Biology Business Overview Table 113. Wuhan Keqian Biology Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Wuhan Keqian Biology Canine Vaccine Product Portfolio Table 115. Wuhan Keqian Biology Recent Development Table 116. SINOVAC Company Information Table 117. SINOVAC Business Overview Table 118. SINOVAC Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. SINOVAC Canine Vaccine Product Portfolio Table 120. SINOVAC Recent Development Table 121. Elanco Company Information Table 122. Elanco Business Overview Table 123. Elanco Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Elanco Canine Vaccine Product Portfolio Table 125. Elanco Recent Development Table 126. Merck Animal Health Company Information Table 127. Merck Animal Health Business Overview Table 128. Merck Animal Health Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Merck Animal Health Canine Vaccine Product Portfolio Table 130. Merck Animal Health Recent Development Table 131. RuiPu Bio-Technology Company Information Table 132. RuiPu Bio-Technology Business Overview Table 133. RuiPu Bio-Technology Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. RuiPu Bio-Technology Canine Vaccine Product Portfolio Table 135. RuiPu Bio-Technology Recent Development Table 136. Zoetis Company Information Table 137. Zoetis Business Overview Table 138. Zoetis Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Zoetis Canine Vaccine Product Portfolio Table 140. Zoetis Recent Development Table 141. CAHIC Company Information Table 142. CAHIC Business Overview Table 143. CAHIC Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. CAHIC Canine Vaccine Product Portfolio Table 145. CAHIC Recent Development Table 146. North America Canine Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. North America Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 148. North America Canine Vaccine Sales Market Share by Country (2021-2026) Table 149. North America Canine Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 150. North America Canine Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. North America Canine Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Canine Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Canine Vaccine Market Share by Country (2021-2026) Table 154. North America Canine Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Canine Vaccine Market Share Forecast by Country (2027-2032) Table 156. Europe Canine Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Europe Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 158. Europe Canine Vaccine Sales Market Share by Country (2021-2026) Table 159. Europe Canine Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 160. Europe Canine Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Canine Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Canine Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Canine Vaccine Market Share by Country (2021-2026) Table 164. Europe Canine Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Canine Vaccine Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Canine Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 168. Asia-Pacific Canine Vaccine Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Canine Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 170. Asia-Pacific Canine Vaccine Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Canine Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Canine Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Canine Vaccine Market Share by Country (2021-2026) Table 174. Asia-Pacific Canine Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Canine Vaccine Market Share Forecast by Country (2027-2032) Table 176. Latin America Canine Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Latin America Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 178. Latin America Canine Vaccine Sales Market Share by Country (2021-2026) Table 179. Latin America Canine Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 180. Latin America Canine Vaccine Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Canine Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Canine Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Canine Vaccine Market Share by Country (2021-2026) Table 184. Latin America Canine Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Canine Vaccine Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Canine Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 188. Middle East and Africa Canine Vaccine Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Canine Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 190. Middle East and Africa Canine Vaccine Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Canine Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Canine Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Canine Vaccine Market Share by Country (2021-2026) Table 194. Middle East and Africa Canine Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Canine Vaccine Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Canine Vaccine Distributors List Table 199. Canine Vaccine Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Canine Vaccine Image Figure 2. Global Canine Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Canine Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Canine Vaccine Sales (2021-2032) & (K Units) Figure 5. Core Vaccines Image Figure 6. Global Core Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 7. Non-Core Vaccines Image Figure 8. Global Non-Core Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Canine Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Canine Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Canine Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Canine Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Canine Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Canine Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Canine Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Canine Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Canine Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Canine Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Canine Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Canine Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Canine Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Puppies Image Figure 24. Global Puppies Sales YoY Growth (2021-2032) & (K Units) Figure 25. Adult Dogs Image Figure 26. Global Adult Dogs Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Canine Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Canine Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Canine Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Canine Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Canine Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Canine Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Canine Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Canine Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Canine Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Canine Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Canine Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Canine Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Canine Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Canine Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Canine Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Canine Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Canine Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Canine Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Canine Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Canine Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Canine Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Canine Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Canine Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Canine Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Canine Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Canine Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Canine Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Canine Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Canine Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Canine Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Canine Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Canine Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Canine Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Canine Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Core Vaccines
  • Non-Core Vaccines
Applications
  • Puppies
  • Adult Dogs
Companies covered
  • Biogenesis Bago
  • Boehringer Ingelheim
  • Durvet
  • NeoTech
  • Virbac
  • Pfizer
  • Jilin Five-Star Animal Health
  • JINHE
  • Wuhan Keqian Biology
  • SINOVAC
  • Elanco
  • Merck Animal Health
  • RuiPu Bio-Technology
  • Zoetis
  • CAHIC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Canine Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Canine Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Canine Vaccine Market by Type
  6. 1.3.1 Core Vaccines
  7. 1.3.2 Non-Core Vaccines
  8. 1.4 Global Canine Vaccine Market Size by Type
  9. 1.4.1 Global Canine Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Canine Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Canine Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Canine Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Canine Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Canine Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Canine Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Canine Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Canine Vaccine Industry Trends
  2. 2.2 Canine Vaccine Industry Drivers
  3. 2.3 Canine Vaccine Industry Opportunities and Challenges
  4. 2.4 Canine Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Canine Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Canine Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Canine Vaccine Price (2021-2026)
  4. 3.4 Global Canine Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Canine Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Canine Vaccine Company, Product Type & Application
  7. 3.7 Global Canine Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Canine Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Canine Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Canine Vaccine Tier 1, Tier 2, and Tier 3
4 Canine Vaccine Regional Status and Outlook
  1. 4.1 Global Canine Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Canine Vaccine Historic Market Size by Region
  3. 4.2.1 Global Canine Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Canine Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Canine Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Canine Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Canine Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Canine Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Canine Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Canine Vaccine by Application
  1. 5.1 Canine Vaccine Market by Application
  2. 5.1.1 Puppies
  3. 5.1.2 Adult Dogs
  4. 5.2 Global Canine Vaccine Market Size by Application
  5. 5.2.1 Global Canine Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Canine Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Canine Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Canine Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Canine Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Canine Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Canine Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Canine Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biogenesis Bago
  2. 6.1.1 Biogenesis Bago Company Information
  3. 6.1.2 Biogenesis Bago Business Overview
  4. 6.1.3 Biogenesis Bago Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biogenesis Bago Canine Vaccine Product Portfolio
  6. 6.1.5 Biogenesis Bago Recent Developments
  7. 6.2 Boehringer Ingelheim
  8. 6.2.1 Boehringer Ingelheim Company Information
  9. 6.2.2 Boehringer Ingelheim Business Overview
  10. 6.2.3 Boehringer Ingelheim Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boehringer Ingelheim Canine Vaccine Product Portfolio
  12. 6.2.5 Boehringer Ingelheim Recent Developments
  13. 6.3 Durvet
  14. 6.3.1 Durvet Company Information
  15. 6.3.2 Durvet Business Overview
  16. 6.3.3 Durvet Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Durvet Canine Vaccine Product Portfolio
  18. 6.3.5 Durvet Recent Developments
  19. 6.4 NeoTech
  20. 6.4.1 NeoTech Company Information
  21. 6.4.2 NeoTech Business Overview
  22. 6.4.3 NeoTech Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 NeoTech Canine Vaccine Product Portfolio
  24. 6.4.5 NeoTech Recent Developments
  25. 6.5 Virbac
  26. 6.5.1 Virbac Company Information
  27. 6.5.2 Virbac Business Overview
  28. 6.5.3 Virbac Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Virbac Canine Vaccine Product Portfolio
  30. 6.5.5 Virbac Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Canine Vaccine Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Jilin Five-Star Animal Health
  38. 6.7.1 Jilin Five-Star Animal Health Company Information
  39. 6.7.2 Jilin Five-Star Animal Health Business Overview
  40. 6.7.3 Jilin Five-Star Animal Health Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Jilin Five-Star Animal Health Canine Vaccine Product Portfolio
  42. 6.7.5 Jilin Five-Star Animal Health Recent Developments
  43. 6.8 JINHE
  44. 6.8.1 JINHE Company Information
  45. 6.8.2 JINHE Business Overview
  46. 6.8.3 JINHE Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 JINHE Canine Vaccine Product Portfolio
  48. 6.8.5 JINHE Recent Developments
  49. 6.9 Wuhan Keqian Biology
  50. 6.9.1 Wuhan Keqian Biology Company Information
  51. 6.9.2 Wuhan Keqian Biology Business Overview
  52. 6.9.3 Wuhan Keqian Biology Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Wuhan Keqian Biology Canine Vaccine Product Portfolio
  54. 6.9.5 Wuhan Keqian Biology Recent Developments
  55. 6.10 SINOVAC
  56. 6.10.1 SINOVAC Company Information
  57. 6.10.2 SINOVAC Business Overview
  58. 6.10.3 SINOVAC Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 SINOVAC Canine Vaccine Product Portfolio
  60. 6.10.5 SINOVAC Recent Developments
  61. 6.11 Elanco
  62. 6.11.1 Elanco Company Information
  63. 6.11.2 Elanco Business Overview
  64. 6.11.3 Elanco Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Elanco Canine Vaccine Product Portfolio
  66. 6.11.5 Elanco Recent Developments
  67. 6.12 Merck Animal Health
  68. 6.12.1 Merck Animal Health Company Information
  69. 6.12.2 Merck Animal Health Business Overview
  70. 6.12.3 Merck Animal Health Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Merck Animal Health Canine Vaccine Product Portfolio
  72. 6.12.5 Merck Animal Health Recent Developments
  73. 6.13 RuiPu Bio-Technology
  74. 6.13.1 RuiPu Bio-Technology Company Information
  75. 6.13.2 RuiPu Bio-Technology Business Overview
  76. 6.13.3 RuiPu Bio-Technology Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 RuiPu Bio-Technology Canine Vaccine Product Portfolio
  78. 6.13.5 RuiPu Bio-Technology Recent Developments
  79. 6.14 Zoetis
  80. 6.14.1 Zoetis Company Information
  81. 6.14.2 Zoetis Business Overview
  82. 6.14.3 Zoetis Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Zoetis Canine Vaccine Product Portfolio
  84. 6.14.5 Zoetis Recent Developments
  85. 6.15 CAHIC
  86. 6.15.1 CAHIC Company Information
  87. 6.15.2 CAHIC Business Overview
  88. 6.15.3 CAHIC Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 CAHIC Canine Vaccine Product Portfolio
  90. 6.15.5 CAHIC Recent Developments
7 North America by Country
  1. 7.1 North America Canine Vaccine Sales by Country
  2. 7.1.1 North America Canine Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Canine Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Canine Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Canine Vaccine Market Size by Country
  6. 7.2.1 North America Canine Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Canine Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Canine Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Canine Vaccine Sales by Country
  2. 8.1.1 Europe Canine Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Canine Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Canine Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Canine Vaccine Market Size by Country
  6. 8.2.1 Europe Canine Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Canine Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Canine Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Canine Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Canine Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Canine Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Canine Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Canine Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Canine Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Canine Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Canine Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Canine Vaccine Sales by Country
  2. 10.1.1 South America Canine Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Canine Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Canine Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Canine Vaccine Market Size by Country
  6. 10.2.1 South America Canine Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Canine Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Canine Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Canine Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Canine Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Canine Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Canine Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Canine Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Canine Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Canine Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Canine Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Canine Vaccine Value Chain Analysis
  2. 12.1.1 Canine Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Canine Vaccine Production Mode & Process
  7. 12.2 Canine Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Canine Vaccine Distributors
  10. 12.2.3 Canine Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst